4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-047649
Chief Scientific Officer sold 11,685 shares at an average $37.47 ($437,885)
- Chief Scientific Officer acquired 11,685 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-19 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-19 | Sale | −1,273 | $36.70 | $46,719 | 71,982 | D: show line 2 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-19 | Sale | −2,622 | $37.33 | $97,879 | 69,360 | D: show line 3 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-20 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D: show line 4 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-20 | Sale | −1,300 | $36.81 | $47,853 | 71,955 | D: show line 5 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-20 | Sale | −2,595 | $37.82 | $98,143 | 69,360 | D: show line 6 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-21 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D: show line 7 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-21 | Sale | −1,400 | $37.29 | $52,206 | 71,855 | D: show line 8 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-21 | Sale | −2,495 | $38.11 | $95,084 | 69,360 | D: show line 9 in the form |
| Open-market sales · 11,685 sh · avg $37.47 · $437,885 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-19 | Option exercise · Stock Option (Right to Buy) | −3,895 | 112,955 | D: show line 10 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-20 | Option exercise · Stock Option (Right to Buy) | −3,895 | 109,060 | D: show line 11 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2021-07-21 | Option exercise · Stock Option (Right to Buy) | −3,895 | 105,165 | D: show line 12 in the form |
Loading xslF345X03/doc4.xml…